MDNA Life Sciences enters collaboration agreement with University of Cambridge to validate Mitochondrial Biomarker blood-based diagnostic for prostate cancer

The study will evaluate the Company’s novel mitochondrial DNA-based test for accurately identifying prostate cancer in blood samples from men with elevated PSA levels that are at risk for prostate cancer.